LumiThera Announces US LIGHTSITE III Clinical Trial…
SEATTLE, LumiThera Inc., a commercial stage medical device company offering photobiomodulation!-->…
SEATTLE, LumiThera Inc., a commercial stage medical device company offering photobiomodulation!-->…
SEOUL, South Korea, March 3, 2022 -- Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo!-->…
Xtalks webinars also provide perspectives on key issues from top industry thought leaders and…
TCAI physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.